Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

No longer available × OTHER × TH 302 × Clear all

Status

Completed 4 Withdrawn 1 Not yet recruiting 1 No longer available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Interventions

fludarabine phosphate 3 Amifampridine 3 gallium 68 PSMA-11 2 fludarabine 2 carbon-11 acetate 2 Magnetic Resonance Spectroscopy 2 Cyclophosphamide 2 3-Iodobenzylguanidine 2 veliparib 1 selinexor 1 pembrolizumab 1 pegfilgrastim 1 omburtamab I-131 1 nirogacestat 1 ganitumab 1 gallium Ga 68 dotatate 1 elotuzumab 1 carfilzomib 1 asparaginase erwinia chrysanthemi recombinant 1 aldesleukin 1 Whole-Body Irradiation 1 Vorinostat 1 Vinorelbine 1 Trabectedin 1 Tacrolimus 1 TH 302 1 Sodium Acetate 1 Potassium Iodide 1 N,N'-bis(2-hydroxy-5-(ethylene-beta-carboxy)benzyl)ethylenediamine N,N'-diacetic acid 1 Mycophenolic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02712567 2016-10-13

SARC021C: A Continuation Study of TH-CR-406/SARC021

Sarcoma Alliance for Research through Collaboration

No longer available

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡